Antony A. Riley

Insider Reports History

Entity
Individual
Location
C/O Krystal Biotech, Inc., 2100 Wharton Street, Suite 701, Pittsburgh, PA
Signature
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Antony A. Riley:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Forte Biosciences, Inc. CHIEF FINANCIAL OFFICER Common Stock 201K $109K $0.55 Jul 1, 2024 Direct
Forte Biosciences, Inc. CHIEF FINANCIAL OFFICER Restricted Stock Units 93.8K $51.2K $0.55 Jul 1, 2024 Direct
Forte Biosciences, Inc. CHIEF FINANCIAL OFFICER Stock Option (right to buy) 350K Mar 21, 2024 Direct

Insider Reports Filed by Antony A. Riley

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FBRX Forte Biosciences, Inc. Jul 1, 2024 3 -$1.83K 4 Jul 3, 2024 CHIEF FINANCIAL OFFICER
FBRX Forte Biosciences, Inc. Apr 1, 2024 3 -$2.37K 4 Apr 2, 2024 CHIEF FINANCIAL OFFICER
FBRX Forte Biosciences, Inc. Mar 21, 2024 1 $0 4 Mar 25, 2024 CHIEF FINANCIAL OFFICER
FBRX Forte Biosciences, Inc. Jan 1, 2024 3 -$3.16K 4 Jan 3, 2024 Chief Financial Officer
FBRX Forte Biosciences, Inc. Oct 1, 2023 3 -$2.15K 4 Oct 3, 2023 Chief Financial Officer
FBRX Forte Biosciences, Inc. Jul 31, 2023 1 $150K 4 Aug 2, 2023 Chief Financial Officer
FBRX Forte Biosciences, Inc. Jul 1, 2023 3 -$3.37K 4 Jul 5, 2023 Chief Financial Officer
FBRX Forte Biosciences, Inc. Apr 1, 2023 3 -$3.27K 4 Apr 4, 2023 Chief Financial Officer
FBRX Forte Biosciences, Inc. Feb 25, 2023 1 $0 4 Feb 27, 2023 Chief Financial Officer
FBRX Forte Biosciences, Inc. Jan 17, 2022 1 $0 4 Jan 18, 2022 Chief Financial Officer
FBRX Forte Biosciences, Inc. Sep 7, 2021 2 -$106K 4 Sep 7, 2021 Chief Financial Officer